Enveric Biosciences, Inc.
Enveric Biosciences, Inc. (ENVB) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ENVB · as of Sep 30, 2025
Ownership Breakdown
11
Institutional Holders
▼ 3 vs Q2
$232,604
Total Inst. Value
▼ $50,610 vs Q2
597,012
Shares Outstanding
freeFloat 91.43%
363,849
13F Shares Held
▲ 129,691 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ENVB largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ADVISORSHARES INVESTMENTS LLC pharmaceutical preparations | 203.7K | 5.42% | 5.42% | $130.23M | Nov 5, 2025 | ▲ 100.0K |
UBS GROUP AG pharmaceutical preparations | 105.3K | 2.80% | 2.80% | $67.31M | Nov 13, 2025 | ▲ 78.0K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 28.5K | 75.85% | 75.85% | $18.23M | Nov 12, 2025 | ▲ 350 |
CITADEL ADVISORS LLC pharmaceutical preparations | 22.7K | 60.32% | 60.32% | $14.50M | Nov 14, 2025 | ▲ 22.7K |
TOWER RESEARCH CAPITAL LLC (TRC) pharmaceutical preparations | 2.4K | 6.43% | 6.43% | $1.55M | Nov 14, 2025 | ▼ 539 |
BLACKROCK, INC. pharmaceutical preparations | 601 | 1.60% | 1.60% | $384,000 | Nov 12, 2025 | — held |
SBI SECURITIES CO., LTD. pharmaceutical preparations | 600 | 1.60% | 1.60% | $384,000 | Nov 5, 2025 | — held |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 26 | 0.07% | 0.07% | $17,000 | Feb 3, 2026 | ▲ 2 |
NATIONAL BANK OF CANADA /FI/ pharmaceutical preparations | 5 | 0.01% | 0.01% | $3,000 | Nov 14, 2025 | — held |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 2 | 0.01% | 0.01% | $1,000 | Nov 13, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
5
Increased
+201.0K shares0
New Positions
first time holders1
Decreased
−539 shares4
Sold Out
fully exitedNet shares change (top 50)
+200.5K
+201.0K / −539
Net new holders
+0
0 new / 4 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ENVB insider trading · insider activity
Source: SEC Form 4
8
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
DeWitt Sheila director | Dec 23, 2025 | Award | 7,633 | — | — | 7.8K | Form 4 ↗ |
Kegler George A. director | Dec 23, 2025 | Award | 7,633 | — | — | 7.9K | Form 4 ↗ |
PASQUALONE FRANK director | Dec 23, 2025 | Award | 7,633 | — | — | 7.9K | Form 4 ↗ |
Schabacker Marcus director | Dec 23, 2025 | Award | 7,633 | — | — | 7.9K | Form 4 ↗ |
Tucker Joseph Edward Chief Executive Officer | Dec 23, 2025 | Award | 60,296 | — | — | 70.4K | Form 4 ↗ |
WEBB MICHAEL D director | Dec 23, 2025 | Award | 7,633 | — | — | 7.9K | Form 4 ↗ |
Coveney Kevin Michael Chief Financial Officer | Dec 23, 2025 | Award | 40,198 | — | — | 47.4K | Form 4 ↗ |
Coveney Kevin Michael CHIEF FINANCIAL OFFICER | May 8, 2025 | Award | 74,150 | — | — | 86.6K | Form 4 ↗ |
Facchini Peter J. CHIEF INNOVATION OFFICER | May 8, 2025 | Award | 24,717 | — | — | 33.1K | Form 4 ↗ |
Tucker Joseph Edward CHIEF EXECUTIVE OFFICER | May 8, 2025 | Award | 98,866 | — | — | 120.7K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Enveric Biosciences, Inc. (ENVB) is primarily owned by institutional investors, who hold approximately 61.0% of total shares outstanding. Company insiders own approximately 8.57%, while retail and public investors account for the remaining 30.49%.
The largest institutional shareholder of Enveric Biosciences, Inc. is ADVISORSHARES INVESTMENTS LLC, holding approximately 203,679 shares — equal to 5.42% of outstanding shares — as of September 30, 2025.
A total of 11 institutional investors currently hold ENVB stock, with a combined institutional value of approximately $232,604 as of the most recent 13F filing period.
Frequently asked questions
ENVB ownershipEnveric Biosciences, Inc. (ENVB) is primarily owned by institutional investors, who hold approximately 61.0% of shares. The largest shareholder is ADVISORSHARES INVESTMENTS LLC with a 5.42% stake. Company insiders hold 8.57%. Data sourced from SEC Form 13F as of September 30, 2025.